Meeting
2013 Genitourinary Cancers Symposium
Evaluation of a genomic-based prognostic test for metastasis in high-risk post-prostatectomy patients: Does it impact physician decision making?
Authors
Ketan K. Badani
Department of Urology, Columbia University College of Physicians & Surgeons, New York, NY
Ketan K. Badani , Darby J. S. Thompson , Anirban Pradip Mitra , Mercedeh Ghadessi , Christine Buerki , Elai Davicioni , Penelope J. Wood
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 31, 2013 (suppl 6; abstr 196)
DOI
10.1200/jco.2013.31.6_suppl.196
Abstract #
196
Poster Bd #
C2
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Prospective randomized trial of genomic classifier impact on treatment decisions in patients at high risk of recurrence following radical prostatectomy (G-MINOR).
First Author: Todd Matthew Morgan
Poster
2018 Genitourinary Cancers Symposium
Impact of decipher test on adjuvant and salvage treatments received following radical prostatectomy.
First Author: John L. Gore
Poster
2016 ASCO Annual Meeting
Effect of a genomic classifier on adjuvant treatment decision-making among patients with high-risk pathology at radical prostatectomy: Results from the multicenter prospective PRO-IMPACT study.
First Author: John L. Gore
Poster
2021 Genitourinary Cancers Symposium
Cell cycle progression score and PTEN as prognostic factors for metastasis in intermediate- and high-risk prostate cancer overall, and in those who also received salvage radiotherapy.
First Author: Bruce J. Trock